GeoVax Labs updates investors on its COVID-19 vaccine and cancer immunotherapy clinical trials
GeoVax Labs CEO David Dodd talks to Proactive about its three separate ongoing Phase II clinical trials in developing a COVID-19 booster to mRNA vaccines, a...